ATE10099T1 - 3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen. - Google Patents

3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.

Info

Publication number
ATE10099T1
ATE10099T1 AT81850039T AT81850039T ATE10099T1 AT E10099 T1 ATE10099 T1 AT E10099T1 AT 81850039 T AT81850039 T AT 81850039T AT 81850039 T AT81850039 T AT 81850039T AT E10099 T1 ATE10099 T1 AT E10099T1
Authority
AT
Austria
Prior art keywords
sup
butyl
ethyl
compounds
preparation
Prior art date
Application number
AT81850039T
Other languages
English (en)
Inventor
Per Gunnar Kjellin
Carl Goeran August Persson
Original Assignee
Aktiebolaget Draco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Draco filed Critical Aktiebolaget Draco
Application granted granted Critical
Publication of ATE10099T1 publication Critical patent/ATE10099T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT81850039T 1980-04-18 1981-03-09 3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen. ATE10099T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8002910A SE8002910L (sv) 1980-04-18 1980-04-18 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
EP81850039A EP0038784B1 (de) 1980-04-18 1981-03-09 3,8-Dialkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE10099T1 true ATE10099T1 (de) 1984-11-15

Family

ID=20340763

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81850039T ATE10099T1 (de) 1980-04-18 1981-03-09 3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.

Country Status (21)

Country Link
US (1) US4546182A (de)
EP (1) EP0038784B1 (de)
JP (1) JPS56166191A (de)
AT (1) ATE10099T1 (de)
AU (1) AU543122B2 (de)
CA (1) CA1156229A (de)
DD (1) DD158400A5 (de)
DE (1) DE3166893D1 (de)
DK (1) DK151631B (de)
ES (1) ES8203088A1 (de)
FI (1) FI69465C (de)
GR (1) GR82347B (de)
HU (1) HU185254B (de)
IE (1) IE51106B1 (de)
NO (1) NO811161L (de)
NZ (1) NZ196829A (de)
PH (1) PH16264A (de)
PL (1) PL134762B1 (de)
PT (1) PT72881B (de)
SE (1) SE8002910L (de)
ZA (1) ZA811729B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
US4710503A (en) * 1985-02-07 1987-12-01 Euroceltique S.A. 6-thioxanthine derivatives
GB8618931D0 (en) * 1986-08-02 1986-09-10 Euro Celtique Sa 6-thioxanthines
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
WO1990012797A1 (en) * 1989-04-19 1990-11-01 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Sulfer-containing xanthine derivatives as adenosin antagonists
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
DE4311538C1 (de) * 1993-04-07 1994-10-06 Boehringer Ingelheim Kg Verfahren zur Herstellung von 1,3-Dimethyl-4,5-diaminouracil
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
US6316423B1 (en) 1996-04-10 2001-11-13 The United States Of America As Represented By The Departmant Of Health And Human Services Method of treating ischemic, hypoxic and anoxic brain damage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53890B2 (de) * 1972-04-22 1978-01-12
CA1077932A (en) * 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
US4089959A (en) * 1976-03-31 1978-05-16 Cooper Laboratories, Inc. Long-acting xanthine bronchodilators and antiallergy agents
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom

Also Published As

Publication number Publication date
NO811161L (no) 1981-10-19
AU6955581A (en) 1981-10-22
PL134762B1 (en) 1985-09-30
PL230737A1 (de) 1982-03-29
JPS56166191A (en) 1981-12-21
ES501400A0 (es) 1982-02-16
NZ196829A (en) 1984-12-14
DE3166893D1 (en) 1984-12-06
DK151631B (da) 1987-12-21
PT72881A (en) 1981-05-01
HU185254B (en) 1984-12-28
IE51106B1 (en) 1986-10-01
EP0038784B1 (de) 1984-10-31
DD158400A5 (de) 1983-01-12
PT72881B (en) 1983-03-29
EP0038784A2 (de) 1981-10-28
ES8203088A1 (es) 1982-02-16
GR82347B (de) 1984-12-13
AU543122B2 (en) 1985-04-04
PH16264A (en) 1983-08-23
SE8002910L (sv) 1981-10-19
FI811212L (fi) 1981-10-19
EP0038784A3 (en) 1982-01-20
FI69465C (fi) 1986-02-10
DK168281A (da) 1981-10-19
CA1156229A (en) 1983-11-01
ZA811729B (en) 1982-04-28
FI69465B (fi) 1985-10-31
US4546182A (en) 1985-10-08
IE810796L (en) 1981-10-18

Similar Documents

Publication Publication Date Title
ES485188A1 (es) Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas
ES8604565A1 (es) Un derivado de acido 6-fluor-1, 4-dihidro-4-oxo-7-piperazinil-quinolin sustituido-3-carboxilico
ATE10099T1 (de) 3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
DE3363550D1 (en) New nitro aliphatic compounds, process for preparation thereof and use thereof
EP0138344A3 (de) Pyridazinonen als beta-adrenergetische Antagonisten
DE3277971D1 (en) Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
ES8307737A1 (es) "un procedimiento para la preparacion de mercapto-acil-carnitinas".
FR2421891A1 (fr) Obtention industrielle d'amides de la pyrrolidine ethyl amine
JPS5239622A (en) Process for preparation of methacrylic acid
DE3262166D1 (en) A new p-chlorophenoxyacetic acid derivative, its method of preparation and pharmaceutical composition
KR890009919A (ko) 4- 헤테로아릴-1,3- 벤조디아제핀 및 2-치환된-α-(헤테로아릴) 벤젠에탄아민, 이의 제조방법 및 약제로서의 이의 용도
JPS5780321A (en) Cardiotonic agent
ZA88640B (en) Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,medicaments containing same,and the use thereof,and some intermediates formed in the preparation of the compounds mentioned
ES8502128A1 (es) Procedimiento para la preparacion de derivados de 6 -metilprednisolona
JPS525782A (en) Preparation of 1-phthalazinone
DE3065093D1 (en) Therapeutic composition based on imidazoles, especially for the treatment of thromboses; imidazoles and process for their preparation
KR830005222A (ko) 만성 폐쇄성 기도 질병 및 심장혈관 질병치료용의 3,8-디알릴크산틴의 제조방법 및 그 조성물과 치료방법
DE3482857D1 (de) 3-aryl-3-pyrrolin-derivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel fuer die bekaempfung von herz- und gefaesskrankheiten.
ATE24715T1 (de) Cycloaliphatische aminosulfonsaeurederivate, verfahren zu deren herstellung und arzneimittel zur bekaempfung von herz- und gefaesskrankheiten.
JPS56169656A (en) Bis(substituted phenoxyacetic acid)-n- alkyldialkanolamine, its manufacture and brain trouble treating agent containing it as major component
JPS53132597A (en) Cytidylic acid derivative and its preparation
KR830001286A (ko) 만성기도장애증과 심장병치료를 위한 3-알킬 크산틴의 제조방법
JPS5278821A (en) Isolation of adipic acid from composition containing glutaric acid, su ccinic acid and adipic acid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee